News
JMP Securities Reiterates Market Outperform on OptimizeRx, Maintains $15 Price Target
16 Apr 24
News, Price Target, Reiteration, Analyst Ratings
OptimizeRx Q4 Adj EPS $0.26, Inline, Sales $28.40M Beat $26.47M Estimate
16 Apr 24
Earnings, News
JMP Securities Initiates Coverage On OptimizeRx with Market Outperform Rating, Announces Price Target of $15
4 Apr 24
News, Price Target, Initiation, Analyst Ratings
Where OptimizeRx Stands With Analysts
1 Apr 24
Analyst Ratings
Stifel Maintains Buy on OptimizeRx, Maintains $13 Price Target
1 Apr 24
News, Price Target, Analyst Ratings
RBC Capital Reiterates Outperform on OptimizeRx, Maintains $17 Price Target
1 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Earnings Scheduled For March 28, 2024
28 Mar 24
Earnings
OptimizeRx Earnings Preview
27 Mar 24
Earnings
OptimizeRx Reaffirms Prior Revenue In The Range Of $68M-$70M Vs $69.85M Est. And Adjusted EBITDA Estimates For FY2023
11 Mar 24
News, Guidance
Press releases
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
18 Apr 24
Analyst Ratings, Press Releases
OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row
11 Apr 24
Press Releases
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
25 Mar 24
News, Press Releases
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
11 Mar 24
News, Press Releases
OptimizeRx Powers Walmart's 'Specialty Pharmacies of the Community' Outreach Effort
4 Mar 24
Health Care, Press Releases, General
OptimizeRx to Participate in Upcoming Investor Conferences
21 Feb 24
News, Press Releases